Abstract:BACKGROUND & AIMS Immune checkpoint inhibitors have limited efficacy in many tumors. We investigated mechanisms of tumor resistance to inhibitors of programmed cell death 1 (PDCD1, also called PD1) in mice with gastric cancer, and the role of its ligand, PDL1. METHODS Gastrin-deficient mice were given N-methyl-N-nitrosourea (MNU) in drinking water along with Helicobacter felis to induce gastric tumor formation; we also performed studies with H/K-ATPase-hIL1B mice, which develop spontaneous gastric tumors at the antral-corpus junction and have parietal cells that constitutively secrete IL1B. Mice were given injections of an antibody against PD1 or an isotype control before tumors developed, or anti-PD1 and 5-fluorouracil and oxaliplatin, or an antibody against lymphocyte antigen 6 complex locus G (also called Gr-1), which depletes myeloid-derived suppressor cells [MDSCs]), after tumors developed. We generated knockin mice that express PDL1 specifically in the gastric epithelium or myeloid lineage. RESULTS When given to gastrin-deficient mice before tumors grew, anti-PD1 significantly reduced tumor size and increased tumor infiltration by T cells. However, anti-PD1 alone did not have significant effects on established tumors in these mice. Neither early nor late anti-PD1 administration reduced tumor growth in the presence of MDSCs in H/K-ATPase-hIL1B mice. The combination of 5-fluorouracil and oxaliplatin reduced MDSCs, increased numbers of intra-tumor CD8+ T cells, and increased the response of tumors to anti-PD1-however, this resulted in increased tumor expression of PDL1. Expression of PDL1 by tumor or immune cells increased gastric tumorigenesis in mice given MNU. Mice with gastric epithelial cells that expressed PDL1 did not develop spontaneous tumors, but they developed more and larger tumors after administration of MNU and H. felis, with accumulation of MDSCs. CONCLUSIONS In mouse models of gastric cancer, 5-fluorouracil and oxaliplatin reduce numbers of MDSCs to increase the effects of anti-PD1, which promotes tumor infiltration by CD8+ T cells. However, these chemotherapeutic agents also induce expression of PDL1 by tumor cells. Expression of PDL1 by gastric epithelial cells increases tumorigenesis in response to MNU and H. felis, and accumulation of MDSCs, which promote tumor progression. The timing and site of PDL1 expression is therefore important in gastric tumorigenesis and should be considered in design of therapeutic regimens.

Hedgehog signaling induces PD-L1 expression and tumor cell proliferation in gastric cancer

Hedgehog transcriptional effector GLI mediates mTOR-Induced PD-L1 expression in gastric cancer organoids

Suppression of Growth and Migration by Blocking the Hedgehog Signaling Pathway in Gastric Cancer Cells

[Hedgehog Signaling Pathway Activates in Gastric Carcinoma and Promotes the Proliferation Through GLI1 in MKN28 Cell].

PD-1 Signaling Promotes Tumor-Infiltrating Myeloid-Derived Suppressor Cells and Gastric Tumorigenesis in Mice.

Abstract LB-091: Hedgehog Signaling Induces Drug Resistance in Gastric Cancer Cells Via Upregulation of ABCG2

Pan-cancer analyses reveal that increased Hedgehog activity correlates with tumor immunosuppression and resistance to immune checkpoint inhibitors

Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation

cDNA microarray gene expression profiling of hedgehog signaling pathway inhibition in human colon cancer cells

Sonic Hedgehog Pathway Contributes to Gastric Cancer Cell Growth and Proliferation

Knockdown of PD-L1 in Human Gastric Cancer Cells Inhibits Tumor Progression and Improves the Cytotoxic Sensitivity to CIK Therapy.

LHPP Suppresses Gastric Cancer Progression Via the PI3K/AKT/mTOR Signaling Pathway.

HSulf-1 Suppresses Cell Growth and Down-Regulates Hedgehog Signaling in Human Gastric Cancer Cells

Autocrine Sonic Hedgehog Signaling Promotes Gastric Cancer Proliferation Through Induction Of Phospholipase C Gamma 1 And The Erk1/2 Pathway

Hedgehog signaling in gastrointestinal carcinogenesis and the gastrointestinal tumor microenvironment

Hedgehog signaling pathway regulates human pancreatic cancer cell proliferation and metastasis.

Hedgehog Signaling in Human Hepatocellular Carcinoma

Autocrine Sonic hedgehog signaling promotes gastric cancer proliferation through induction of phospholipase Cγ1 and the ERK1/2 pathway

Conditional Medium of Gastric Cancer Mesenchymal Stem Cells Promotes PD-L1 Expression in Gastric Cancer Cells and Tumor Growth Via Upregulating VGLL4

GPR137 inactivates Hippo signaling to promote gastric cancer cell malignancy

Inhibition of HHIP Promoter Methylation Suppresses Human Gastric Cancer Cell Proliferation and Migration